Research programme: cancer therapy - Digital Gene Technologies
Latest Information Update: 22 Sep 2006
At a glance
- Originator Digital Gene Technologies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 18 May 2001 Preclinical development for Cancer in USA (Unknown route)
- 18 May 2001 New profile